WHO ICTRP trial
Combination of 5-Fluorouracil/Folinate/Oxaliplatin (Eloxatin®) (FLOX regimen)…
EUCTR2005-000117-34-SE · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2005-000117-34-SE |
|---|---|
| Public title | Combination of 5-Fluorouracil/Folinate/Oxaliplatin (Eloxatin®) (FLOX regimen) with Concomitant or Concomitant and Maintenance Administration of Cetuximab (Erbitux®), in First-Line Treatment of Metastatic Colorectal Cancer. - Nordic VII |
| Scientific title | Combination of 5-Fluorouracil/Folinate/Oxaliplatin (Eloxatin®) (FLOX regimen) with Concomitant or Concomitant and Maintenance Administration of Cetuximab (Erbitux®), in First-Line Treatment of Metastatic Colorectal Cancer. - Nordic VII |
| Primary sponsor | The Nordic Colorectal Cancer Biomodulation Group |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Finland;Iceland;Denmark;Sweden |
| Conditions | Patient with metastatic colorectal cancer. |
| Interventions | Product Name: Erbitux® Product Code: EMD271786 Pharmaceutical Form: Solution for infusion INN or Proposed INN: Cetuximab CAS Number: 205923-56-4 Current Sponsor code: EMD271786 Other descriptive name: Cetuximab Concentration unit: mg/ml… |
| Registration date | Oct 3, 2005 |
| Target size | 550 |
| Secondary IDs | Nordic VII |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: